1Gomez Candela, C, Olivar Roldan, J, Garcia, M, et al. (2010) Assessment of a malnutrition screening tool in cancer patients. Nutr Hosp 25, 400–405.
2Gomez-Candela, C, Luengo, LM, Cos, AI, et al. (2003) Subjective global assessment in neoplastic patients. Nutr Hosp 18, 353–357.
3Agius, R, Nadulski, T, Kahl, HG, et al. (2010) Validation of a headspace solid-phase microextraction-GC–MS/MS for the determination of ethyl glucuronide in hair according to forensic guidelines. Forensic Sci Int 196, 3–9.
4Trabal, J, Leyes, P, Forga, MT, et al. (2006) Quality of life, dietary intake and nutritional status assessment in hospital admitted cancer patients. Nutr Hosp 21, 505–510.
5Bossola, M, Pacelli, F, Tortorelli, A, et al. (2007) Cancer cachexia: it's time for more clinical trials. Ann Surg Oncol 14, 276–285.
6Murry, DJ, Riva, L & Poplack, DG (1998) Impact of nutrition on pharmacokinetics of anti-neoplastic agents. Int J Cancer Suppl 11, 48–51.
7Laky, B, Janda, M, Kondalsamy-Chennakesavan, S, et al. (2010) Pretreatment malnutrition and quality of life – association with prolonged length of hospital stay among patients with gynecological cancer: a cohort study. BMC Cancer 10, 232–237.
8Capra, S, Ferguson, M & Ried, K (2001) Cancer: impact of nutrition intervention outcome – nutrition issues for patients. Nutrition 17, 769–772.
9Sosa-Sanchez, R, Sanchez-Lara, K, Motola-Kuba, D, et al. (2008) The cachexia–anorexia syndrome among oncological patients. Gac Med Mex 144, 435–440.
10Gupta, D, Lammersfeld, CA, Vashi, PG, et al. (2005) Prognostic significance of Subjective Global Assessment (SGA) in advanced colorectal cancer. Eur J Clin Nutr 59, 35–40.
11Wong, PW, Enriquez, A & Barrera, R (2001) Nutritional support in critically ill patients with cancer. Crit Care Clin 17, 743–767.
12Arrieta, O, Michel Ortega, RM, Villanueva-Rodriguez, G, et al. (2010) Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel–cisplatin chemotherapy: a prospective study. BMC Cancer 10, 50.
13Dufau, L (2010) Prevalencia de desnutrición en pacientes oncológicos (Prevalence of malnutrition in cancer patients). Diaeta 28, 31–36.
14Tchekmedyian, NS (1995) Costs and benefits of nutrition support in cancer. Oncology 9, 79–84.
15Segura, A, Pardo, J, Jara, C, et al. (2005) An epidemiological evaluation of the prevalence of malnutrition in Spanish patients with locally advanced or metastatic cancer. Clin Nutr 24, 801–814.
16Dewys, WD, Begg, C, Lavin, PT, et al. (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69, 491–497.
17Zorlini, R, Akemi Abe Cairo, A & Salete Costa Gurgel, M (2008) Nutritional status of patients with gynecologic and breast cancer. Nutr Hosp 23, 577–583.
18Laky, B, Janda, M, Bauer, J, et al. (2007) Malnutrition among gynaecological cancer patients. Eur J Clin Nutr 61, 642–646.
19Fuchs, V & Gutierrez, G (2008) Situación nutricional en pacientes oncológicos internados en un hospital público de la ciudad de México (Nutritional status in cancer patients admitted to a public hospital in Mexico City). Rev Cubana Med 47, 1–5.
20Prado, CM, Lieffers, JR, McCargar, LJ, et al. (2008) Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 9, 629–635.
21Lipkin, EW & Bell, S (1993) Assessment of nutritional status. The clinician's perspective. Clin Lab Med 13, 329–352.
22Gudny Geirsdottir, O & Thorsdottir, I (2008) Nutritional status of cancer patients in chemotherapy; dietary intake, nitrogen balance and screening. Food Nutr Res 52 .
23Prado, CM, Baracos, VE, McCargar, LJ, et al. (2009) Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res 15, 2920–2926.
24Prado, CM, Baracos, VE, McCargar, LJ, et al. (2007) Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity. Clin Cancer Res 13, 3264–3268.
25Marin Caro, MM, Gomez Candela, C, Castillo Rabaneda, R, et al. (2008) Nutritional risk evaluation and establishment of nutritional support in oncology patients according to the protocol of the Spanish Nutrition and Cancer Group. Nutr Hosp 23, 458–468.
26Collins, MM, Wight, RG & Partridge, G (1999) Nutritional consequences of radiotherapy in early laryngeal carcinoma. Ann R Coll Surg Engl 81, 376–831.
27Laky, B, Janda, M, Cleghorn, G, et al. (2008) Comparison of different nutritional assessments and body-composition measurements in detecting malnutrition among gynecologic cancer patients. Am J Clin Nutr 87, 1678–1685.
28Jagoe, RT, Goodship, TH & Gibson, GJ (2001) The influence of nutritional status on complications after operations for lung cancer. Ann Thorac Surg 71, 936–943.
29Edington, J, Winter, PD, Coles, SJ, et al. (1999) Outcomes of undernutrition in patients in the community with cancer or cardiovascular disease. Proc Nutr Soc 58, 655–661.
30Sánchez-Lara, K, Turcott, J, Sosa-Sánchez, R, et al. (2008) Evaluación del estado de nutrición en el paciente con cancer (Assessment of nutritional status in patients with cancer). Rev Endocrinol Nut 16, 165–171.
31Walsh, D, Donnelly, S & Rybicki, L (2000) The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients. Support Care Cancer 8, 175–179.
32Grosvenor, M, Bulcavage, L & Chlebowski, RT (1989) Symptoms potentially influencing weight loss in a cancer population. Correlations with primary site, nutritional status, and chemotherapy administration. Cancer 63, 330–334.
33Cid Conde, L, Fernandez Lopez, T, Neira Blanco, P, et al. (2008) Hyponutrition prevalence among patients with digestive neoplasm before surgery. Nutr Hosp 23, 46–53.
34Sarhill, N, Mahmoud, F, Walsh, D, et al. (2003) Evaluation of nutritional status in advanced metastatic cancer. Support Care Cancer 11, 652–659.